What is CAGR? What does CAGR table indicate for Earum Pharmaceuticals Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Earum Pharmaceuticals Ltd Stock Analysis

Q: Is Earum Pharmaceuticals Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Earum Pharmaceuticals Ltd and arrived at the following conclusion.

Q: Is the current market price of Earum Pharmaceuticals Ltd a good price to buy it?

The 5-year analysis of Earum Pharmaceuticals Ltd's performance infers.

Q: What is Earum Pharmaceuticals Ltd share price return in the past 10 years?

We analysed the performance of Earum Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Small Cap

Evaluated by 25 users | BSE: 542724 | NSE: |
Trading

Earum Pharmaceuticals Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Capital Employed	11.64%	14.73%	17.86%	17.35%	12.74%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	18.6	23.3	35.4	50.7	55.1
Y-o-Y Gr. Rt.	-	25.7%	51.8%	43.1%	8.7%
Adjusted EPS (Rs.)	9.45	13.33	29.18	54.14	2.95
Y-o-Y Gr. Rt.	-	41.1%	118.9%	85.5%	-94.6%
Book Value per Share (Rs.)	127.18	142.07	142.06	192.66	23.37
Adjusted Net Profit	0.1	0.1	0.9	1.7	1.8
Net Op. Cash Flow (Rs. Cr.)	-0.3	0.1	-7.1	-0.5	-3.5
Debt to Cash Flow from Ops	-7.21	24.11	-1.02	-19.97	-2.69

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Earum Pharmaceuticals Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Earum Pharmaceuticals Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	NA	NA	33.2%	8.7%
Adjusted EPS	NA	NA	-39.5%	-94.6%
Book Value per Share	0	0	-45.2	-87.9
Share Price	-	-	-	70.6%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Equity (%)	7.43	9.9	27.98	30.78	17.9
Operating Profit Margin (%)	2.81	1.72	4.39	6.54	2.26
Net Profit Margin (%)	0.55	0.61	2.54	3.29	3.31
Debt to Equity	1.39	1.37	1.65	1.61	0.64
Working Capital Days	0	149	155	151	182
Cash Conversion Cycle	0	71	89	96	112

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	70.04%
Non-Institutions	29.96%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Earum Pharmaceuticals Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Earum Pharmaceuticals Ltd a good price to buy it?

Data is not available for this company.

3. What is Earum Pharmaceuticals Ltd share price return in the past 10 years ?

Data is not available for this company

About Company

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.

Business area of the company

The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.

Read Less